Nurix Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q2 2021 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Nurix Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q2 2021 to Q4 2023.
  • Nurix Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending November 30, 2023 was $42.4M, a 9.13% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $42.4M -$4.26M -9.13% Nov 30, 2023 10-K 2024-02-15
Q4 2022 $46.7M +$33.7M +258% Nov 30, 2022 10-K 2023-02-09
Q3 2022 $48.1M Aug 31, 2022 10-Q 2022-10-06
Q2 2022 $49.5M +$45.7M +1202% May 31, 2022 10-Q 2022-07-07
Q1 2022 $16.5M Feb 28, 2022 10-Q 2022-04-08
Q4 2021 $13M Nov 30, 2021 10-K 2022-01-28
Q2 2021 $3.8M Jul 31, 2021 10-Q 2022-04-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.